Protara Therapeutics, Inc. (TARA)

Price & Market Data

Price: $4.92

Daily Change: -$0.05 / 1.02%

Daily Range: $4.82 - $5.05

Market Cap: $276,524,832

Daily Volume: 1,126,038

Performance Metrics

1 Week: -3.02%

1 Month: -6.48%

3 Months: -29.73%

6 Months: -23.11%

1 Year: 50.30%

YTD: -7.18%

About Protara Therapeutics, Inc. (TARA)

Dive into the latest financial snapshot of Protara Therapeutics, Inc. (TARA). With a current trading price of 4.92, the stock has experienced a daily shift of -$0.05 / 1.02%. The company's market capitalization stands impressively at 276,524,832. Track its year-to-date performance, which is at -7.18%, alongside its weekly, monthly, and yearly trends.

Company Details

Employees: 51

Sector: Health technology

Industry: Pharmaceuticals: major

Country: United States

Details

Protara Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in advancing transformative therapies for the treatment of cancer and rare diseases. The company's lead program is TARA-002, an investigational cell therapy, which is in Phase II clinical trial for the treatment of non-muscle invasive bladder cancer and lymphatic malformations. It is also developing intravenous choline chloride, an investigational phospholipid substrate replacement therapy for patients receiving parenteral nutrition and fluids. The company is headquartered in New York, New York.

Selected stocks

Interlink Electronics, Inc. (LINK)

XCF Global, Inc. (SAFX)

Information Services Group, Inc. (III)

Lead Real Estate Co., Ltd (LRE)

Repay Holdings Corporation (RPAY)